{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T02:52:46Z","timestamp":1782442366830,"version":"3.54.5"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T00:00:00Z","timestamp":1770508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T00:00:00Z","timestamp":1770508800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100014468","name":"Mallinckrodt Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014468","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pulm Ther"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1007\/s41030-026-00344-3","type":"journal-article","created":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T04:27:51Z","timestamp":1770524871000},"page":"385-395","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Symptomatic Sarcoidosis Treated with Acthar\u00ae Gel: Insights from a Physician-Reported Chart Review"],"prefix":"10.1007","volume":"12","author":[{"given":"Amit","family":"Patel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyanka P.","family":"Shanbhag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Destri R.","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyle","family":"Hayes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary P.","family":"Panaccio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna","family":"Purcell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1140-740X","authenticated-orcid":false,"given":"George J.","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,8]]},"reference":[{"issue":"10","key":"344_CR1","first-page":"840","volume":"93","author":"N Soto-Gomez","year":"2016","unstructured":"Soto-Gomez N, Peters JI, Nambiar AM. Diagnosis and management of sarcoidosis. Am Fam Physician. 2016;93(10):840\u20138.","journal-title":"Am Fam Physician"},{"issue":"9923","key":"344_CR2","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1016\/S0140-6736(13)60680-7","volume":"383","author":"D Valeyre","year":"2014","unstructured":"Valeyre D, Prasse A, Nunes H, Uzunhan Y, Brillet PY, Muller-Quernheim J. Sarcoidosis. Lancet. 2014;383(9923):1155\u201367. https:\/\/doi.org\/10.1016\/S0140-6736(13)60680-7.","journal-title":"Lancet"},{"issue":"8","key":"344_CR3","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1513\/AnnalsATS.201511-760OC","volume":"13","author":"RP Baughman","year":"2016","unstructured":"Baughman RP, Field S, Costabel U, et al. Sarcoidosis in America. Analysis based on health care use. Ann Am Thorac Soc. 2016;13(8):1244\u201352. https:\/\/doi.org\/10.1513\/AnnalsATS.201511-760OC.","journal-title":"Ann Am Thorac Soc"},{"key":"344_CR4","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.117.007844","author":"N Patel","year":"2018","unstructured":"Patel N, Kalra R, Doshi R, et al. Hospitalization rates, prevalence of cardiovascular manifestations, and outcomes associated with sarcoidosis in the United States. J Am Heart Assoc. 2018. https:\/\/doi.org\/10.1161\/JAHA.117.007844.","journal-title":"J Am Heart Assoc"},{"key":"344_CR5","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.04079-2020","author":"RP Baughman","year":"2021","unstructured":"Baughman RP, Valeyre D, Korsten P, et al. ERS clinical practice guidelines on treatment of sarcoidosis. Eur Respir J. 2021. https:\/\/doi.org\/10.1183\/13993003.04079-2020.","journal-title":"Eur Respir J"},{"issue":"5","key":"344_CR6","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1097\/MCP.0000000000000704","volume":"26","author":"M Sharp","year":"2020","unstructured":"Sharp M, Eakin MN, Drent M. Socioeconomic determinants and disparities in sarcoidosis. Curr Opin Pulm Med. 2020;26(5):568\u201373. https:\/\/doi.org\/10.1097\/MCP.0000000000000704.","journal-title":"Curr Opin Pulm Med"},{"key":"344_CR7","doi-asserted-by":"publisher","DOI":"10.1177\/1753466619888127","volume":"13","author":"I Chopra","year":"2019","unstructured":"Chopra I, Qin Y, Kranyak J, et al. Repository corticotropin injection in patients with advanced symptomatic sarcoidosis: retrospective analysis of medical records. Ther Adv Respir Dis. 2019;13:1753466619888127. https:\/\/doi.org\/10.1177\/1753466619888127.","journal-title":"Ther Adv Respir Dis"},{"issue":"21","key":"344_CR8","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.1056\/NEJMra071714","volume":"357","author":"MC Iannuzzi","year":"2007","unstructured":"Iannuzzi MC, Rybicki BA, Teirstein AS. Sarcoidosis. N Engl J Med. 2007;357(21):2153\u201365. https:\/\/doi.org\/10.1056\/NEJMra071714.","journal-title":"N Engl J Med"},{"issue":"2","key":"344_CR9","first-page":"312","volume":"70","author":"JJ Wu","year":"2004","unstructured":"Wu JJ, Schiff KR. Sarcoidosis. Am Fam Physician. 2004;70(2):312\u201322.","journal-title":"Am Fam Physician"},{"issue":"2","key":"344_CR10","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s41030-023-00222-2","volume":"9","author":"M Mirsaeidi","year":"2023","unstructured":"Mirsaeidi M, Baughman RP, Sahoo D, Tarau E. Results from a phase 4, multicenter, randomized, double-blind, placebo-controlled study of repository corticotropin injection for the treatment of pulmonary sarcoidosis. Pulm Ther. 2023;9(2):237\u201353. https:\/\/doi.org\/10.1007\/s41030-023-00222-2.","journal-title":"Pulm Ther"},{"issue":"9","key":"344_CR11","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1080\/13696998.2018.1474750","volume":"21","author":"JB Rice","year":"2018","unstructured":"Rice JB, White AG, Johnson M, et al. Healthcare resource use and cost associated with varying dosages of extended corticosteroid exposure in a US population. J Med Econ. 2018;21(9):846\u201352. https:\/\/doi.org\/10.1080\/13696998.2018.1474750.","journal-title":"J Med Econ"},{"issue":"8","key":"344_CR12","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1080\/03007995.2018.1474090","volume":"34","author":"JB Rice","year":"2018","unstructured":"Rice JB, White AG, Johnson M, et al. Quantitative characterization of the relationship between levels of extended corticosteroid use and related adverse events in a US population. Curr Med Res Opin. 2018;34(8):1519\u201327. https:\/\/doi.org\/10.1080\/03007995.2018.1474090.","journal-title":"Curr Med Res Opin"},{"issue":"10","key":"344_CR13","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/S2213-2600(15)00199-X","volume":"3","author":"RP Baughman","year":"2015","unstructured":"Baughman RP, Grutters JC. New treatment strategies for pulmonary sarcoidosis: antimetabolites, biological drugs, and other treatment approaches. Lancet Respir Med. 2015;3(10):813\u201322. https:\/\/doi.org\/10.1016\/S2213-2600(15)00199-X.","journal-title":"Lancet Respir Med"},{"key":"344_CR14","unstructured":"Mallinckrodt Pharmaceuticals. Acthar\u00ae Gel (repository corticotropin injection): Prescribing Information. 2024. https:\/\/www.acthar.com\/Static\/pdf\/Acthar-PI.pdf. Accessed 3 Aug 2025."},{"key":"344_CR15","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0146-2019","author":"FF Rahaghi","year":"2020","unstructured":"Rahaghi FF, Baughman RP, Saketkoo LA, et al. Delphi consensus recommendations for a treatment algorithm in pulmonary sarcoidosis. Eur Respir Rev. 2020. https:\/\/doi.org\/10.1183\/16000617.0146-2019.","journal-title":"Eur Respir Rev"},{"key":"344_CR16","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.rmed.2015.11.007","volume":"110","author":"RP Baughman","year":"2016","unstructured":"Baughman RP, Barney JB, O\u2019Hare L, Lower EE. A retrospective pilot study examining the use of Acthar gel in sarcoidosis patients. Respir Med. 2016;110:66\u201372. https:\/\/doi.org\/10.1016\/j.rmed.2015.11.007.","journal-title":"Respir Med"},{"issue":"3","key":"344_CR17","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/s00408-017-9994-4","volume":"195","author":"RP Baughman","year":"2017","unstructured":"Baughman RP, Sweiss N, Keijsers R, et al. Repository corticotropin for chronic pulmonary sarcoidosis. Lung. 2017;195(3):313\u201322. https:\/\/doi.org\/10.1007\/s00408-017-9994-4.","journal-title":"Lung"},{"key":"344_CR18","doi-asserted-by":"publisher","DOI":"10.7573\/dic.2021-10-4","author":"H Busch","year":"2022","unstructured":"Busch H, Wan GJ, Niewoehner J, et al. Real-world treatment patterns for repository corticotropin injection in patients with rheumatoid arthritis. Drugs Context. 2022. https:\/\/doi.org\/10.7573\/dic.2021-10-4.","journal-title":"Drugs Context"},{"key":"344_CR19","doi-asserted-by":"publisher","first-page":"315","DOI":"10.2147\/OARRR.S329766","volume":"13","author":"K Hayes","year":"2021","unstructured":"Hayes K, Panaccio MP, Houston P, et al. Real-world treatment patterns and outcomes from an electronic medical records database for patients with rheumatoid arthritis treated with repository corticotropin injection. Open Access Rheumatol. 2021;13:315\u201323. https:\/\/doi.org\/10.2147\/OARRR.S329766.","journal-title":"Open Access Rheumatol"}],"container-title":["Pulmonary Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s41030-026-00344-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s41030-026-00344-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s41030-026-00344-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T02:02:32Z","timestamp":1773712952000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s41030-026-00344-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,8]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["344"],"URL":"https:\/\/doi.org\/10.1007\/s41030-026-00344-3","relation":{},"ISSN":["2364-1754","2364-1746"],"issn-type":[{"value":"2364-1754","type":"print"},{"value":"2364-1746","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,8]]},"assertion":[{"value":"1 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Amit Patel, Priyanka Shanbhag, and Destri Evans are employees of Indegene, Inc., are paid consultants for this study, and declare that they have no other conflicts of interest. Kyle Hayes, Johanna Purcell, and George J. Wan are employees of Keenova Therapeutics, affiliated with Mallinckrodt Pharmaceuticals and declare that they have no other conflicts of interest. Mary Panaccio is a paid consultant for this study and declares that she has no other conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}},{"value":"This study used preexisting fully deidentified data, with no direct involvement of human subjects or access to identifiable private information. Based on the authors\u2019 determination and in accordance with the U.S. Department of Health and Human Services (45 CFR 46.102) and FDA (21 CFR 56.102) regulations, this work does not meet the definition of human subjects research. Therefore, approval from an institutional review board or ethics committee was not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}